Intentar ORO - Gratis
Championing a Culture Where Purpose Powers Progress
Fortune US
|December 2025 - January 2026
Averitas Pharma is making a meaningful difference by putting its people and patients first.
-
AVERITAS PHARMA, A GRÜNENTHAL COMPANY, approaches pain as a disease in urgent need of a solution, not just a symptom to be managed.
Leading with a patient-first mindset, the company is driven by empathy for those living with chronic pain. This powers its purpose of making a difference in the lives of appropriate patients by advancing how pain and its impact are understood and treated.
Based in Morristown, N.J., Averitas has built its reputation on care that extends from science to everyday life. Its culture combines scientific focus with a deep respect for the people who make its mission possible—its employees and the patients it serves.
That commitment continues to earn Averitas recognition as a Great Place To Work
Esta historia es de la edición December 2025 - January 2026 de Fortune US.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Fortune US
Fortune US
GET READY TO OWN A TOKENIZED PORTFOLIO
A BLOCKCHAIN \"FREIGHT TRAIN\" IS ALREADY REMAKING WALL STREET'S FINANCIAL PLUMBING. IT COULD MAKE TRADING EVEN FASTER AND CHEAPER
6 mins
December 2025 - January 2026
Fortune US
RESOURCES HOW RARE EARTHS BECAME GROUND ZERO IN THE U.S.-CHINA RIVALRY
THE WATERSHED moment came in July when the federal government became the largest shareholder of MP Materials, a California miner of rare earth elements.
2 mins
December 2025 - January 2026
Fortune US
PASSIONS A BLISSFUL ESCAPE FROM DECISION FATIGUE
THE TASTING MENU at Uberto ends, like many others at restaurants of this caliber, with mignardises.
4 mins
December 2025 - January 2026
Fortune US
JAMIE DIMON OF JPMORGAN CHASE ON STEERING AMERICA'S BIGGEST BANK THROUGH 'INFLATIONARY' TIMES
CEO JAMIE DIMON has led JPMorgan Chase through periods of rapid change and epic turmoil—and Jan. 1, 2026, will be his 20th anniversary in the role.
6 mins
December 2025 - January 2026
Fortune US
WHAT TO BUY, AND NOT BUY, IN 2026
THREE YEARS OF EUPHORIA IN STOCKS AND OTHER ASSETS HAVE INVESTORS BRACING FOR TROUBLE. HERE'S WHAT TO DO IF BAD NEWS ARRIVES.
7 mins
December 2025 - January 2026
Fortune US
Breaking the Mold
The Trade Desk's Al-powered platform and open-web ethos has propelled it onto the S&P 500.
2 mins
December 2025 - January 2026
Fortune US
WINE TARIFF THREATS AND GEN Z SOBRIETY HAVE PUT BORDEAUX ON RED ALERT
IN THE TASTING room of a Bordeaux winery, a photo on the wall shows a pastoral tableau: three generations of the Dubois family, sipping wine on the patio of their Les Bertrands château, with their Australian shepherd, Namek, perched at their feet.
6 mins
December 2025 - January 2026
Fortune US
HOW AN AI BUBBLE COULD RUIN THE PARTY
IF AI REVENUE DOESN'T CATCH UP WITH AI SPENDING, GLOBAL STOCKS WILL BE AT RISK.
6 mins
December 2025 - January 2026
Fortune US
INNOVATION IS THE ERA OF ROBOT-DRIVEN UNEMPLOYMENT ALMOST UPON US?
AT A PRESS EVENT LAST YEAR, Amazon Robotics chief technologist Tye Brady told Fortune that the idea that there's a battle of robots versus humans inside Amazon's warehouse network is a “myth.”
5 mins
December 2025 - January 2026
Fortune US
Nvidia is invincible. Unless it isn't.
The doubters are coming for the world's most valuable company.
11 mins
December 2025 - January 2026
Listen
Translate
Change font size
